.jpg)
Medacta® Group is an industrial group mainly active in the field of production and sales of medical products.Its history begins in 1958, when Bieffe Biochimici Firenze was founded by Dr. Francesco
Siccardi Senior.This group has enjoyed a prosperous growth thanks to cutting edge technology, a world-wide expansion and excellent commercial results.
The Group has expanded its activity all over the world, specialising in the field of dialysis, urology and i.v. perfusion.In 1997 the Siccardi family sold a big part of the activity to Baxter Group i.e. the sterile fluids product group.Subsequently the Siccardi family re-invested part of its capital into the field of orthopaedics and so founded Medacta® International SA.In 2001Medacta® was certified with the following standards – ISO 9001 and ISO 13485.
In 2007 Medacta® Australia was established – the first Medacta® subsidiary outside Europe and in
2008 Medacta® USA was established. In the same year Medacta® received the first FDA clearance for its products.In 2009 Strategic decision to start the Medacta® Spine Division and in 2010 1st Spine Division Product Mectalif® is implanted.In 2011 Medacta® Japan was established, entering the Asian market. In the same year 1st Spine Division Product is implanted in the US.Today a solid management and the important capital influx are the base of the new Medacta® Group, represented in 21 countries worldwide.